Drugs for Lipid Metabolism Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 320)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Empagliflozin |
Approved |
Phase 4 |
|
864070-44-0 |
73151030 11949646 |
Synonyms:
(1S)-1,5-ANHYDRO-1-(4-CHLORO-3-{4-[(3S)-TETRAHYDROFURAN-3-YLOXY]BENZYL}PHENYL)-D-GLUCITOL
(1S)-1,5-ANHYDRO-1-C-{4-CHLORO-3-((4-{((3S)-OXOLAN-3-YL)OXY}PHENYL)METHYL)PHENYL}-D-GLUCITOL
1-CHLORO-4-(GLUCOPYRANOS-1-YL)-2-(4-(TETRAHYDROFURAN-3-YLOXY)BENZYL)BENZENE
BI 10773
BI 10773|Jardiance®
BI10773
|
BI-10773
EMPAGLIFLOZIN
Empagliflozina
Empagliflozine
Empagliflozinum
JARDIANCE
|
|
2 |
|
Tocopherol |
Approved, Investigational |
Phase 4 |
|
1406-66-2 |
|
Synonyms:
Methyltocols
tocoferol
tocoferoles
|
|
|
3 |
|
Aripiprazole |
Approved, Investigational |
Phase 4 |
|
129722-12-9 |
60795 |
Synonyms:
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
Abilify
ABILIFY MAINTENA
ABILIFY MAINTENA KIT
ABILIFY MYCITE KIT
Abilify®|Aripiprex®|Aristada® (aripiprazole lauroxil)|OPC 14597|OPC-14597
Abilitat
Aripiprazol
|
ARIPIPRAZOLE
Aripiprazolum
ARIPIPREX
OPC 14597
OPC 31
OPC-14597
OPC-31
|
|
4 |
|
Pravastatin |
Approved |
Phase 4 |
|
81093-37-0 |
54687 |
Synonyms:
(+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8ar)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoate
(+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8ar)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acid
(3R,5R)-7-[(1S,2S,6S,8S,8AR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
3beta-Hydroxycompactin
Apo pravastatin
Apo-pravastatin
Apotex brand OF pravastatin sodium
Aventis brand OF pravastatin sodium
Bristacol
Bristol-myers squibb brand OF pravastatin sodium
C10AA03
Compactin
Elisor
Eptastatin
Esteve brand OF pravastatin sodium
Juste brand OF pravastatin sodium
Lin pravastatin
Lin-pravastatin
Linson pharma brand OF pravastatin sodium
Lipemol
Liplat
Lipostat
Lipostat®|Pravachol®|pravastatin sodium
Mevalothin
Mevalotin
Mevastatin
Mevinolin
Nu pravastatin
Nu-pharma brand OF pravastatin sodium
Nu-pravastatin
|
Oliprevin
Prareduct
Pravachol
Pravacol
Pravaselect
Pravasin
PRAVASTATIN
Pravastatin acid
Pravastatin monosodium salt, (6 beta)-isomer
Pravastatin sodium
Pravastatin sodium salt
Pravastatin tert octylamine salt
Pravastatin tert-octylamine salt
Pravastatin, (6 beta)-isomer
Pravastatina
Pravastatina [Spanish]
Pravastatine
Pravastatine [French]
Pravastatinum
Pravastatinum [Latin]
Pravator
RMS 431
RMS-431
Sankyo brand OF pravastatin sodium
Selectin
Selektine
Selipran
Sodium salt, pravastatin
Squibb brand OF pravastatin sodium
Vasten
|
|
5 |
|
Rosiglitazone |
Approved, Investigational |
Phase 4 |
|
122320-73-4, 155141-29-0 |
77999 |
Synonyms:
(±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione
(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion
5-((4-(2-(Methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate
AVANDAMET
AVANDARYL
Avandia
Avandia®|rosiglizole
BRL-49653
BRL-49653C
BRL-49653-C
Gaudil
|
Glaxo wellcome brand OF rosiglitazone maleate
GlaxoSmithKline brand OF rosiglitazone maleate
Rosigliazone maleate
Rosiglitazon
Rosiglitazona
Rosiglitazone
Rosiglitazone maleate
Rosiglitazonum
Rosiglizole
SmithKline beecham brand OF rosiglitazone maleate
TDZ-01
|
|
6 |
|
Pioglitazone |
Approved, Investigational |
Phase 4 |
|
111025-46-8 |
4829 |
Synonyms:
(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
(±)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-(4-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione
5-{4-[2-(5-ETHYLPYRIDIN-2-YL)ETHOXY]BENZYL}-1,3-THIAZOLIDINE-2,4-DIONE
Actos
Actos®|Glustin®|pioglitazone HCl|U-72107A
Actost
AD-4833
DUETACT
Glustin
Pioglitazona
Pioglitazona [INN-Spanish]
|
PIOGLITAZONE
Pioglitazone [Ban:Inn]
Pioglitazone HCL
Pioglitazone hydrochloride
Pioglitazonum
Pioglitazonum [INN-Latin]
Poglitazone hydrochloride
U-72107
U-72107A
XAB907
ZACTOS
|
|
7 |
|
Efavirenz |
Approved, Investigational |
Phase 4 |
|
154598-52-4 |
64139 |
Synonyms:
(-)-6-CHLORO-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[D][1,3]oxazin-2-one
6-Chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[D][1,3]oxazin-2-one
Bristol-myers squibb brand OF efavirenz
DMP 266
DMP-266
DMP-266|DMP266|EFV|L-743,726|L-743726|Stocrin®|Sustiva®
Du pont brand OF efavirenz
|
Efavirenz
Éfavirenz
Efavirenz, (R)-isomer
Efavirenz, (S)-isomer
Efavirenzum
EFV
Merck sharp and dohme brand OF efavirenz
Stocrin
Sustiva
SUSTIVA 600
United drug brand OF efavirenz
|
|
8 |
|
Nevirapine |
Approved |
Phase 4 |
|
129618-40-2 |
4463 |
Synonyms:
11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO(3,2-B
11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
2',3'-E)(1,4)DIAZEPIN-6-ONE
ABBR NVP
BI RG 587
BIRG-0587
BIRG587
BI-RG-587
Hemihydrate, nevirapine
NEV
|
Nevirapina
NEVIRAPINE
NEVIRAPINE ANHYDROUS
Nevirapine hemihydrate
Nevirapine, anhydrous
NSC-641530
NVP
Viramune
VIRAMUNE XR
|
|
9 |
|
Coconut |
Approved |
Phase 4 |
|
|
|
10 |
|
Losartan |
Approved |
Phase 4 |
|
114798-26-4 |
3961 |
Synonyms:
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
[<sup>3</sup>H]-losartan
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
Cozaar
Cozaar®|DuP 753|MK-954
DuP 753
DUP 89
DuP-753
HGP1405
HGP-1405
|
Hyzaar
Lortaan
LOSARTAN
Losartan monopotassium salt
Losartan potassium
Losartic
MK-954
Monopotassium salt, losartan
Potassium, losartan
Salt, losartan monopotassium
|
|
11 |
|
Dapagliflozin |
Approved |
Phase 4 |
|
461432-26-8 |
9887712 |
Synonyms:
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
BMS-512148
BMS-512148|Farxiga®|Forxiga®
BMS-512148-05
|
Dapagliflozin
Dapagliflozina
FARXIGA
FORXIGA
|
|
12 |
|
Olmesartan |
Approved, Investigational |
Phase 4 |
|
144689-63-4, 144689-24-7 |
158781 130881 |
Synonyms:
(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid
(5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(Hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid
4-(Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
4-(Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate - T287346
866, CS
Benicar
Benicar HCT
Benicar®|CS-866|Olmetec®
|
CS-866
DE-092
HCT, Benicar
Medoxomil, olmesartan
OLMESARTAN
Olmesartan medoximil
Olmesartan medoxomil
Olmesartan medoxomil tablets
Olmetec
Omesartan
RNH-6270
Votum
|
|
13 |
|
Orange |
Approved |
Phase 4 |
|
|
|
14 |
|
Ritonavir |
Approved, Investigational |
Phase 4 |
|
155213-67-5 |
392622 |
Synonyms:
538, ABT
A-84538
A-84538|ABBOTT-84538|ABT 538|ABT-538|Norvir®|RTV
Abbott 84538
ABBOTT-84538
ABT 538
ABT-538
|
N-[(1S,3S,4S)-1-BENZYL-3-HYDROXY-5-PHENYL-4-{[(1,3-THIAZOL-5-YLMETHOXY)CARBONYL]AMINO}PENTYL]-N~2~-(METHYL{[2-(1-METHYLETHYL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)-L-VALINAMIDE
Norvir
Norvir Sec
NSC-693184
Ritonavir
RITONAVIR RELATED COMPOUNDS MIXTURE
Ritonavirum
|
|
15 |
|
Acetylsalicylic acid |
Approved, Vet_approved |
Phase 4 |
|
50-78-2 |
2244 |
Synonyms:
2-(ACETYLOXY)BENZOATE
2-(ACETYLOXY)benzoIC ACID
2-Acetoxybenzenecarboxylate
2-ACETOXYBENZENECARBOXYLIC ACID
2-ACETOXYBENZOATE
2-ACETOXYBENZOIC ACID
2-CARBOXYPHENYL ACETATE
8-HOUR BAYER
A.S.A.
A.S.A. Empirin
ACARD
ACENTERINE
Acesal
Acetal
ACETARD
ACETICYL
Acetilsalicilico
Acetilum acidulatum
Acetisal
ACETOL
ACETONYL
ACETOPHEN
Acetophen®|acetylsalicylic acid|Aspirin®
ACETOSAL
ACETOSALIC ACID
ACETOSALIN
Acetoxybenzoic acid
ACETYLIN
Acetylsal
ACETYLSALIC ACID
ACETYLSALICYLATE
ACETYLSALICYLIC ACID
Acetylsalicylsaeure
Acetylsalicylsaure
ACETYLSALICYLSÄURE
ACETYONYL
ACETYSAL
ACETYSALICYLIC ACID
Acid, acetylsalicylic
Acide 2-(acetyloxy)benzoique
ACIDE 2-(ACÉTYLOXY)BENZOÏQUE
Acide acetylsalicylique
ACIDE ACÉTYLSALICYLIQUE
Acido acetilsalicilico
ÁCIDO ACETILSALICÍLICO
Acido O-acetil-benzoico
ACIDUM ACETYLSALICYLICUM
Acimetten
Acisal
ACYLPYRIN
Adiro
ALKA RAPID
Aloxiprimum
ANADIN ALL NIGHT
ANGETTES 75
ASA
Asagran
ASATARD
Ascoden-30
Aspalon
Aspec
ASPERGUM
ASPIRDROPS
ASPIRIN
Aspirina
Aspirine
Aspro
ASPRO CLR
Asteric
Azetylsalizylsaeure
AZETYLSALIZYLSÄURE
BAY1019036
BAYER EXTRA STRENGTH
Bayer Extra Strength Aspirin For Migraine Pain
BENASPIR
Bialpirina
BIALPIRINIA
Bi-prin
BUFFERIN
CAPRIN
CARDIOASPIRINA
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
DANAMEP
Decaten
Delgesic
Dispril
DISPRIN CV
|
DISPRIN DIRECT
Dolean pH 8
Duramax
DURLAZA
EASPRIN
ECM
ECOLEN
ECOTRIN
EMPIRIN
ENDOSPRIN
ENDYDOL
ENPRIN
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
EQUI-PRIN
Extren
GENCARDIA
Globentyl
Globoid
Helicon
Idragin
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LEVIUS
Magnecyl
MAX STRGH ASPRO CLR
MEASURIN
Micristin
MICROPIRIN EC
Neuronika
Novid
NSC-27223
NSC-406186
Nu-seals
NU-SEALS 300
NU-SEALS 600
NU-SEALS 75
Nu-seals aspirin
NU-SEALS CARDIO 75
O-(ACETYLOXY)BENZOATE
O-(ACETYLOXY)BENZOIC ACID
O-accetylsalicylic acid
O-ACETOXYBENZOATE
O-ACETOXYBENZOIC ACID
O-Acetylsalicylate
O-ACETYLSALICYLIC ACID
O-CARBOXYPHENYL ACETATE
O-Carboxyphenyl acetic acid
PAYNOCIL
PERSISTIN
PHARMACIN
Pirseal
PLATET
PLATET 300
Polopirin
POLOPIRYNA
POSTMI 300
POSTMI 75
PREMASPIN
RHEUMINTABLETTEN
RHODINE
Rhonal
Salacetin
SALCETOGEN
SALETIN
Salicylate acetate
SALICYLIC ACID ACETATE
Salicylic acid acetic acid
Salicylic acid, acetate
SALOSPIR
Solfrin
SOLPRIN
SOLPRIN ACID
SOLPYRON
Solupsan
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
TASPRIN
TEMPERAL
TOLDEX
TRIAMINICIN
Triple-sal
Vanquish
VAZALORE
Xaxa
Yasta
Zorprin
|
|
16 |
|
Bilberry |
Approved, Experimental |
Phase 4 |
|
|
|
Synonyms:
Bilberry fruit
Dried billberry fruit (vaccinium myrtillus l.)
Dwarf bilberry
Dwarf bilberry fruit
European blueberry
European blueberry fruit
Fresh billberry fruit (vaccinium myrtillus l.)
Myrtilli fructus
Myrtilli fructus recens (vaccinium myrtillus l.)
Myrtilli fructus siccus (vaccinium myrtillus l.)
|
Myrtillus
Myrtle blueberry
Myrtle blueberry fruit
Myrtle whortleberry
Myrtle whortleberry fruit
Vaccinium myrtillus
Vaccinium myrtillus dry fruit
Vaccinium myrtillus fruit
Whortleberry
|
|
17 |
|
Irbesartan |
Approved, Investigational |
Phase 4 |
|
138402-11-6 |
3749 |
Synonyms:
2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-N-Butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one
Aprovel
Aprovel®|Avapro®|Karvea®|SR 47436
Avalide
Avapro
BMS 186295
BMS-186295
|
IFIRMASTA
Irbesarran
IRBESARTAN
Irbesartan [Usan:Inn]
Karvea
Lrbesartan
SABERVEL
SR-47436
|
|
18 |
|
Candesartan cilexetil |
Approved |
Phase 4 |
|
145040-37-5 |
|
Synonyms:
1-(Cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylic acid
1-Cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
Amias
Atacand
Blopress
CANDESARTAN
|
Candesartan cilexetil
Kenzen
Parapres
RATACAND
TCV 116
TCV-116
|
|
19 |
|
Bezafibrate |
Approved, Investigational |
Phase 4 |
|
41859-67-0 |
39042 |
Synonyms:
2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionate
2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid
Azufibrat
Azupharma brand OF bezafibrate
Bayer brand OF bezafibrate
Befibrat
Befizal
Béfizal
Berlin chemie brand OF bezafibrate
Berlin-chemie brand OF bezafibrate
Betapharm brand OF bezafibrate
Beza lande
Beza puren
Bezabeta
Bezacur
Bezafibrat
Bezafibrat PB
BEZAFIBRATE
Bezafibrate azupharma brand
Bezafibrate bayer brand
Bezafibrate berlin-chemie brand
Bezafibrate betapharm brand
Bezafibrate cryopharma brand
Bezafibrate elfar brand
Bezafibrate hennig brand
Bezafibrate hexal brand
Bezafibrate isis brand
Bezafibrate lakeside brand
Bezafibrate merckle brand
Bezafibrate roche brand
Bezafibrate synthelabo brand
Bezafibrate tad brand
Bezafibrate teva brand
Bezafibrato
Bezafibratum
Bezafibric acid
Bezafisal
BEZAGEN XL
|
Beza-lande
BezaLande
Bezalip
Bezalip®
BEZALIP-MONO
Bezamerck
Beza-puren
BezaPuren
Bezatol SR
BEZATOL SR (TN)
BM 15.075
BM-15.075
BM-15075
Boehringer mannheim brand OF bezafibrate
Cedur
Cryopharma brand OF bezafibrate
Difaterol
Durabezur
Elfar brand OF bezafibrate
Eulitop
FIBRAZATE XL
Hennig brand OF bezafibrate
Hexal brand OF bezafibrate
Isis brand OF bezafibrate
Lakeside brand OF bezafibrate
LIPAROL XL
Lipox
Merckle brand OF bezafibrate
PB, Bezafibrat
Reducterol
Regadrin b
Roche brand OF bezafibrate
Sklerofibrat
Solibay
Synthelabo brand OF bezafibrate
TAD brand OF bezafibrate
Teva brand OF bezafibrate
ZIMBACOL XL
|
|
20 |
|
Sirolimus |
Approved, Investigational |
Phase 4 |
|
53123-88-9 |
5284616 6436030 |
Synonyms:
(-)-Rapamycin
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
Antibiotic ay 22989
AY-22989
AY-22989|Fyarro® (sirolimus albumin-bound particles)|Rapamune®|rapamycin|WY-090217
L04AA10
NSC-226080
Perceiva
RAPA
Rapammune
|
Rapamune
Rapamycin
Rapamysin
RPM
Sirolimus
Sirolimús
Sirolimusum
SM-88 COMPONENT SIROLIMUS
WY-090217
|
|
21 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 4 |
|
22916-47-8 |
4189 |
Synonyms:
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
Brentan
CONOFITE
Dactarin
DERMAZOLE
DUMICOAT
Esteve brand OF miconazole
florid(nitrate)|Monistat®|R-14889
Janssen cilag brand OF miconazole
Janssen-cilag brand OF miconazole
Johnston and johnston brand OF miconazole nitrate
LORAMYC
MCZ
MICATIN
|
Miconasil nitrate
Miconazol
Miconazole
Miconazole esteve brand
Miconazole janssen-cilag brand
Miconazole nitrate
Miconazolum
Monistat
MONISTAT-3
MONISTAT-DERM
Nitrate, miconasil
Nitrate, miconazole
NSC-170986
Oravig
VUSION
|
|
22 |
|
Clotrimazole |
Approved, Vet_approved |
Phase 4 |
|
23593-75-1 |
2812 |
Synonyms:
(Chlorotrityl)imidazole
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole
1-(a-(2-Chlorophenyl)benzhydryl)imidazole
1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole
1-(O-Chloro-a,a-diphenylbenzyl)imidazole
1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole
1-(O-Chlorotrityl)imidazole
1-(O-Chloro-α,α-diphenylbenzyl)imidazole
1-(Α-(2-chlorophenyl)benzhydryl)imidazole
ABTRIM
ACTAVALL
Bay b 5097
BAY-5097
Bayer brand 1 OF clotrimazole
Bayer brand 2 OF clotrimazole
CANDIDEN
Canesten
Canesten 1-day cream combi-pak
Canesten 1-day therapy
Canesten 3-day therapy
Canesten 6-day therapy
CANESTEN AF
Canesten combi-pak 1-day therapy
Canesten combi-pak 3-day therapy
Canesten cream
CANESTEN CRM COMBI
CANESTEN INTERNAL
Canesten solution
CANESTEN VC
Canesten®|Lotrimin®
Canestine
Chlotrimazole
Clotrimaderm
Clotrimaderm cream
Clotrimazol
CLOTRIMAZOLE
Clotrimazole schering brand
Clotrimazolum
Desamix F
Empecid
FB b 5097
Fem care
FemCare
FUNGEDERM
GNF-PF-3499
Gyne lotrimin
Gyne-lotrimin
Gyne-lotrimin 3
Gyne-lotrimin 3 combination pack
Gyne-lotrimin combination pack
Gyne-lotrimin3
Gyne-lotrimin3 combination pack
|
Gynix
Kanesten
Klotrimazole
Lopac-C-6019
Lotrimax
Lotrimin
LOTRIMIN (TN)
Lotrimin af
Lotrimin af cream
Lotrimin af jock-itch cream
Lotrimin af lotion
Lotrimin af solution
Lotrimin cream
Lotrimin lotion
Lotrimin solution
Lotrisone
MASNODERM
mono-Baycuten
Monobaycuten
Mycelax
Mycelex
MYCELEX (TN)
Mycelex 7
Mycelex cream
Mycelex g
Mycelex otc
Mycelex solution
Mycelex troches
Mycelex twin pack
Mycelex: mycosporinrimazole
Mycelex-7
Mycelex-7 combination pack
Mycelex-g
MYCIL GOLD
Myclo cream
Myclo solution
Myclo spray solution
Myclo-gyne
Mycosporin
Mykosporin
Neo-zol cream
NSC-257473
Otomax
Pedisafe
Prestwick_120
PRIVACOM
Rimazole
Schering brand OF clotrimazole
Tibatin
Trimysten
Trivagizole 3
Veltrim
|
|
23 |
|
Lopinavir |
Approved |
Phase 4 |
|
192725-17-0 |
92727 |
Synonyms:
378, ABT
A-157378.0
A-157378-0
ABT 378
ABT-378
ABT-378a-157378-0a-157378.0
Aluviran
Kaletra
|
Koletra
LOPINAVIR
LPV
N-(4-(((2,6-Dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide
SID124893167
SID144205757
SID50111692
|
|
24 |
|
Ciprofibrate |
Approved, Investigational |
Phase 4 |
|
52214-84-3 |
2763 |
Synonyms:
CIPROFIBRATE
Ciprofibrato
Ciprofibratum
Ciprofibric acid
Hyperlipen
|
Lipanor
Lipanor®|Modalim®|WIN-35833
Modalim
Oroxadin
WIN-35833
|
|
25 |
|
Mecobalamin |
Approved, Investigational |
Phase 4 |
|
13422-55-4 |
|
Synonyms:
ASIMIL B-12
B-MAX
CO-METHYLCOBALAMIN
MeCbl
Mecobalamin
Mecobalamina
|
Mecobalaminum
Methyl vitamin B12
Methyl(III)cobalamin
Methylcob(III)alamin
Methylcobalamin
|
|
26 |
|
Hydroxocobalamin |
Approved |
Phase 4 |
|
13422-51-0 |
15589840 44475014 |
Synonyms:
a-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
alpha Cobione
alpha-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
ALPHAREDISOL
Axlon
Ciplamin H
Cobalex
Cobalin H
COBALIN-H
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosylbenzimidazole inner salt
Codroxomin
CYANOKIT
Docclan
Docelan
Docevita
Droxomin
Ducobee hy
Duradoce
|
Duralta-12
HEPAVIT
Hydrocobalamin
Hydrogrisevit
Hydrovit
Hydroxocobalamin
Hydroxo-cobalamin
HYDROXOCOBALAMIN ACETATE
HYDROXOCOBALAMIN ANHYDROUS
Hydroxocobalamine
HYDROXOCOBALAMINUM ANHYDROUS
HYDROXOCOBEMINE
Hydroxomin
Hydroxycobalamin
MEGAMILBEDOCE
NEO-CYTAMEN
OH-CBL
Vitamin b-12b
|
|
27 |
|
Deoxycholic acid |
Approved |
Phase 4 |
|
83-44-3 |
222528 |
Synonyms:
(3a,5a,12a)-3,12-DIHYDROXYCHOLAN-24-Oate
(3a,5a,12a)-3,12-DIHYDROXYCHOLAN-24-Oic acid
(3a,5b,12a)-3,12-Dihydroxycholan-24-Oate
(3a,5b,12a)-3,12-Dihydroxycholan-24-Oic acid
(3alpha,5alpha,12alpha)-3,12-DIHYDROXYCHOLAN-24-Oate
(3ALPHA,5ALPHA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID
(3alpha,5beta,12alpha)-3,12-Dihydroxycholan-24-Oate
(3alpha,5beta,12alpha)-3,12-Dihydroxycholan-24-Oic acid
(3Α,5α,12α)-3,12-dihydroxycholan-24-Oate
(3Α,5α,12α)-3,12-dihydroxycholan-24-Oic acid
(3Α,5β,12α)-3,12-dihydroxycholan-24-Oate
(3Α,5β,12α)-3,12-dihydroxycholan-24-Oic acid
12beta-Isomer deoxycholic acid
3a,12a-Dihydroxy-5b-cholanate
3a,12a-Dihydroxy-5b-cholanic acid
3alpha,12alpha-Dihydroxy-5beta-cholanate
3alpha,12alpha-Dihydroxy-5beta-cholanic acid
3beta-Isomer deoxycholic acid
3Α,12α-dihydroxy-5β-cholanate
3Α,12α-dihydroxy-5β-cholanic acid
5alpha-Isomer deoxycholic acid
5b-Cholanic acid-3a,12a-diol
5b-Deoxycholate
5b-Deoxycholic acid
7a-Deoxycholate
7a-Deoxycholic acid
7alpha-Deoxycholate
7alpha-Deoxycholic acid
7-Deoxycholate
7-Deoxycholic acid
7Α-deoxycholate
7Α-deoxycholic acid
Acid, 5alpha-isomer deoxycholic
Acid, choleic
Acid, deoxycholic
Acid, desoxycholic
Acid, dihydroxycholanoic
|
Acid, lagodeoxycholic
ATX-101
ATX-101|DCA|deoxycholate
Choleic acid
Cholerebic
Cholorebic
Degalol
Deoxycholatate
Deoxycholate
Deoxy-cholate
Deoxycholate, sodium
Deoxycholatic acid
Deoxycholic acid
Deoxy-cholic acid
Deoxycholic acid, 12beta isomer
Deoxycholic acid, 12beta-isomer
Deoxycholic acid, 3beta isomer
Deoxycholic acid, 3beta-isomer
Deoxycholic acid, 5alpha isomer
Deoxycholic acid, 5alpha-isomer
Deoxycholic acid, disodium salt
Deoxycholic acid, magnesium (2:1) salt
Deoxycholic acid, monoammonium salt
Deoxycholic acid, monopotassium salt
Deoxycholic acid, monosodium salt
Deoxycholic acid, sodium salt, 12beta-isomer
Desoxycholate
Desoxycholic acid
Desoxycholsaeure
Desoxycholsäure
Dihydroxycholanoic acid
DWJ211
DWJ-211
KYBELLA
Lagodeoxycholic acid
NSC-8797
Sodium deoxycholate
|
|
28 |
|
Levoleucovorin |
Approved, Experimental, Investigational |
Phase 4 |
|
68538-85-2, 58-05-9, 73951-54-9 |
149436 6006 |
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R)-Leucovorin
(6R,2'S)-Folinic acid
(6R,S)-5-Formyltetrahydrofolate
(6S)-5-Formyl-5,6,7,8-tetrahydrofolate
(6S)-5-FORMYL-5,6,7,8-TETRAHYDROFOLIC ACID
(6S)-5-Formyltetrahydrofolate
(6S)-5-FORMYLTETRAHYDROFOLIC ACID
(6S)-Folinate
(6S)-FOLINIC ACID
(6S)-LEUCOVORIN
(S)-LEUCOVORIN
[6R]-5-formyl-5,6,7,8-tetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formlyl-5,6,7,8-tetrahydrofolate,calcium salt
5-Formyl-(6S)-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formylTHF
6 S Leucovorin
6R-Leucovorin
6S Leucovorin
6S-Leucovorin
6-S-Leucovorin
Acid, folinic
Acide folinique
Acido folinico
ácido levofolínico
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
CF
Citrovorum factor
Dextrofolinic acid
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
FUSILEV
KHAPZORY
|
Kunyrin
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucoverin
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, (S)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, (S)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monopotassium salt, (S)-isomer
Leucovorin, monosodium salt
Leucovorin, monosodium salt, (S)-isomer
Leucovorinum
Leukovorin
Leukovorum
Levo leucovorin
LEVOFOLENE
Levofolinate
LEVOFOLINIC ACID
Levoleucovorin
Levo-leucovorin
L-Folinate
L-FOLINIC ACID
LFP-754
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamate
N-[4-({[(6S)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID
N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
N5-Formyl-THF
Pteroyl-D-glutamate
Rescuvolin
S Leucovorin
S-Leucovorin
Welcovorin
Wellcovorin
|
|
29 |
|
Lamivudine |
Approved, Investigational |
Phase 4 |
|
134678-17-4 |
60825 |
Synonyms:
(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
(-)-2'-Deoxy-3'-thiacytidine
2',3' Dideoxy 3' thiacytidine
2',3'-Dideoxy-3'-thiacytidine
3TC
3'-Thia-2',3'-dideoxycytidine
BCH 189
BCH 189, (-)-
BCH-189
beta-L-2',3'-Dideoxy-3'-thiacytidine
beta-L-3'-Thia-2',3'-dideoxycytidine
b-L-2',3'-Dideoxy-3'-thiacytidine
b-L-3'-Thia-2',3'-dideoxycytidine
Epivir
|
EPIVIR-HBV
Epzicom
GR-109714X
Hepitec
HEPTOVIR
LAMIVUDIN
LAMIVUDINA
LAMIVUDINE
Lamivudine [Usan:Ban:Inn]
Lamivudine, (2S-cis)-isomer
LAMIVUDINUM
ZEFFIX
Î’-L-2',3'-dideoxy-3'-thiacytidine
Î’-L-3'-thia-2',3'-dideoxycytidine
|
|
30 |
|
Zidovudine |
Approved |
Phase 4 |
|
30516-87-1 |
35370 |
Synonyms:
3' Azido 2',3' dideoxythymidine
3' Azido 3' deoxythymidine
3'-Azido-2',3'-dideoxythymidine
3'-Azido-3'-deoxythymidine
Antiviral azt
Apo-Zidovudine
Azidothymidine
AZT
AZT (antiviral)
AZT antiviral
AZT, antiviral
Aztec
BW a509U
BWA 509u
BWA509u
|
BWA-509u
BW-A509U
BW-A-509U
COMPOUND S
COMPOUND-S
Novo-Azt
NSC-602670
Retrovir
ZDV
Zidovudin
Zidovudina
Zidovudine
Zidovudine EP III
Zidovudinum
|
|
31 |
|
Calcium polycarbophil |
Approved |
Phase 4 |
|
126040-58-2 |
|
Synonyms:
Calcium polycarbophil
Polycarbophil calcium
|
|
|
32 |
|
Pitavastatin |
Approved |
Phase 4 |
|
147511-69-1 |
5282452 |
Synonyms:
(e,3R,5S)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid
Itavastatin
Itavastatin calcium
itavastatin|Livalo®
Livalo
Nisvastatin
NK 104
NK-104
|
NKS104
Pitavastatia
PITAVASTATIN
Pitavastatin calcium
Pitavastatin lactone
Pitavastatina
Pitavastatine
Pitavastatinum
|
|
33 |
|
English walnut |
Approved |
Phase 4 |
|
|
|
34 |
|
Fenofibric acid |
Approved |
Phase 4 |
|
42017-89-0 |
64929 |
Synonyms:
FENOCOR-67
Fenofibrate
FENOFIBRATE FREE ACID
FENOFIBRATE RELATED COMPOUND B
FENOFIBRIC ACID
FENOGAL
FIBRICOR
LF-153
|
LIPANTHYL
LIPOFEN
LOFIBRA
NSC-281318
Procetofenate
Procetofenic acid
SUPRALIP
TRILIPIX
|
|
35 |
|
Fenofibrate |
Approved |
Phase 4 |
|
49562-28-9 |
3339 |
Synonyms:
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoate 1-methylethyl ester
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester
Abbott brand OF procetofen
ABT-335
ABT-335|Lipantil®|Supralip®|Tricor®
AbZ brand OF procetofen
Aliud brand OF procetofen
Ankebin
Antara
Antara micronized procetofen
Anto brand OF procetofen
Apo feno micro
Apo fenofibrate
Apo-fenofibrate
Apo-feno-micro
Apotex brand OF procetofen
AZU, fenofibrat
Azupharma brand OF procetofen
Betapharm brand OF procetofen
Bouchara brand OF procetofen
CiL
Controlip
CT Arzneimittel brand OF procetofen
CT-Arzneimittel brand OF procetofen
Debat, fénofibrate
Durafenat
Elasterate
Elasterin
Fenobeta
Fenobrate
Fenofanton
Fenofibrat abz
Fenofibrat al
Fenofibrat azu
Fenofibrat FPH
Fenofibrat heumann
Fenofibrat hexal
Fenofibrat ratiopharm
Fenofibrat stada
Fenofibrat von CT
FENOFIBRATE
Fénofibrate debat
Fénofibrate MSD
FENOFIBRATO
Fenofibrato [INN-Spanish]
Fenofibrat-ratiopharm
FENOFIBRATUM
Fenofibratum [INN-Latin]
Fenofibric acid
FENOGAL
FENOGLIDE
Fenotard
Finofibrate
Finofibric acid
FNF
Fournier brand OF procetofen
gate Brand OF procetofen
Gen fenofibrate
Gen-fenofibrate
Genpharm brand OF procetofen
GNR Pharma brand OF procetofen
GNR-Pharma brand OF procetofen
Heumann brand OF procetofen
Heumann, fenofibrat
Hexal brand OF procetofen
Hexal, fenofibrat
Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate
Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionic acid
Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate
|
Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionic acid
Knoll brand OF procetofen
Lichtenstein brand OF procetofen
Lipanthyl
Lipantil
LIPANTIL (TN)
LIPANTIL MICRO 200
LIPANTIL MICRO 267
LIPANTIL MICRO 67
Liparison
Lipidex
Lipidil
Lipidil Micro
Lipidil Supra
Lipidil ter
Lipidil-ter
Lipifen
Lipirex
Lipoclar
Lipofen
Lipofene
Liposit
Lipsin
Livesan
Lofibra
Luxacor
Merck dura brand OF procetofen
Micronized procetofen, antara
MTW Brand OF procetofen
MTW Fenofibrat
MTW-Fenofibrat
Nolipax
Normalip
Novartis brand OF procetofen
Novo fenofibrate
Novo-fenofibrate
Novopharm brand OF procetofen
NSC-281319
Nu fenofibrate
Nu pharm brand OF procetofen
Nu-fenofibrate
Nu-pharm brand OF procetofen
Pharmascience brand OF procetofen
Phenofibrate
PMS Fenofibrate micro
PMS-Fenofibrate micro
Procetofen
Procetofen reliant brand
Procetofen, antara micronized
Procetofene
Proctofene
Protolipan
Q Pharm brand OF procetofen
Q-Pharm brand OF procetofen
Ratiopharm brand OF procetofen
Reliant brand OF procetofen
Schering plough brand OF procetofen
Schering-plough brand OF procetofen
Secalip
Sedufen
Stada, fenofibrat
Stadapharm brand OF procetofen
Supralip
SUPRALIP 160
Tricor
TRICOR (TN)
Triglide
Trilipix
United drug brand OF procetofen
|
|
36 |
|
Nicotinamide |
Approved, Investigational |
Phase 4 |
|
98-92-0 |
936 |
Synonyms:
3 Pyridinecarboxamide
3-Carbamoylpyridine
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
Acid amide
Amid kyseliny nikotinove
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra brand OF niacinamide
Austrovit PP
b 3, Vitamin
b3, Vitamin
Benicot
beta-Pyridinecarboxamide
b-Pyridinecarboxamide
Delonin amide
Dipegyl
Dipigyl
Endobion
Enduramide
Factor PP
FREEDERM
Hansamid
Inovitan PP
Jenapharm brand OF niacinamide
Jenapharm, nicotinsäureamid
m-(Aminocarbonyl)pyridine
Mediatric
Merck brand OF niacinamide
NAM
Nandervit-N
Niacevit
Niacin
Niacinamide
Niacinamide astra brand
Niacinamide jenapharm brand
Niacinamide merck brand
Niacinamide pharmagenix brand
Niamide
NIATIN
Niavit PP
NICAM
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
|
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamide
Nicotinamidum
Nicotinate amide
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsäureamid jenapharm
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Niocinamide
Niozymin
NSC-13128
NSC-27452
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix brand OF niacinamide
PP-Faktor
Propamine a
PYRIDINE-3-CARBOXAMIDE
Pyridine-3-carboxylic acid amide
Savacotyl
Vi-nicotyl
Vi-noctyl
Vitamin b 3
Vitamin b3
Vitamin PP
Witamina PP
Î’-pyridinecarboxamide
|
|
37 |
|
Evolocumab |
Approved |
Phase 4 |
|
1256937-27-5 |
|
Synonyms:
AMG-145
AMG-145|AMG145|Repatha®
EVOLOCUMAB
|
REPATHA
REPATHA SURECLICK
|
|
38 |
|
DL-alpha-Tocopherol |
Approved, Experimental, Investigational, Nutraceutical, Vet_approved |
Phase 4 |
|
59-02-9, 10191-41-0 |
2116 14985 |
Synonyms:
(-)-a-Tocopherol
(-)-Α-tocopherol
(+)-2R,4’R,8’R-α-Tocopherol
(+)-2R,4'R,8'R-alpha-Tocopherol
(+)-2R,4'R,8'R-α-Tocopherol
(+)-alpha-Tocopherol
(+)-a-Tocopherol
(+)-α-Tocopherol
(±)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4’R,8’R)-α-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'r,8'r)-a-Tocopherol
(2R,4'R,8'R)-α-Tocopherol
(all-R)-alpha-Tocopherol
(all-R)-α-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-α-Tocopherol
3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-(2R)-2H-1-benzopyran-6-ol
5,7,8-Trimethyltocol
a-D-Tocopherol
all-rac-alpha-tocopherol
Almefrol
ALPHA TOCOPHEROL
alpha-delta-Tocopherol
alpha-D-Tocopherol
alpha-Tocopherol
alpha-Vitamin E
Amino-Opti-E
AQUASOL E
a-Tocopherol
d-alpha-Tocopherol
Daltose
|
D-a-Tocopherol
delta-alpha-Tocopherol
Denamone
DL-5,7,8-trimethyltocol
DL-alpha tocopherol
DL-α-tocopherol
d-α-Tocopherol
E-200 I.U. Softgels
E307
E-Complex-600
E-Ferol
Emipherol
Eprolin
Etamican
E-VIMIN
E-Vitamin succinate
Evitaminum
Gordo-Vite E
NATOPHEROL
Phytogermin
Phytogermine
Profecundin
RRR-alpha-Tocopherol
RRR-alpha-Tocopheryl
TOCOPHEROL
Vitamin e
Vitamin E DL-alpha
Vitamin ea
Vitamin Ealpha
Vitamin Eα
Vitamin Plus E Softgells
Vitec
α-D-Tocopherol
α-Tocopherol
α-Vitamin E
|
|
39 |
|
Cyanocobalamin |
Approved, Nutraceutical |
Phase 4 |
|
68-19-9 |
24892734 16212801 44176380 |
Synonyms:
Anacobin
Bedoz
BEHEPAN
Berocca PN
Berubigen
BETALIN 12
Betalin 12 crystalline
Betaline-12
Betolvex
Bevidox
Bevidox concentrate
Biocobalamine
Byladoce
Cabadon m
CALOMIST
Cernevit-12
Cianocobalamina
Cobadoce forte
Cobalin
Cobavite
Cobex
Cobolin-M
Copharvit 5000
Covit
Crystamin
Crystamine
Crysti-12
Crystimin
Crystwel
Cyano-b12
Cyanobalamin concentrate
Cyanocob(III)alamin
CYANOCOBALAMIN
Cyanocobalamin (JP15/usp)
Cyanocobalamin Co 57 Schilling Test Kit
Cyanocobalamine
Cyanocobalaminum
Cyanocobalmin
Cyanoject
CYANOVIT-B12
Cycobemin
Cycolamin
Cykobemin
Cykobeminet
Cyomin
Cyredin
Cytacon
Cytamen
Cytobion
Depinar
Dicopac
Dicopac Kit
Dimethylbenzimidazoylcobamide
Distivit
Docemine
Docibin
Docivit
Dodecabee
Dodecavite
Dodex
Duodecibin
Embiol
Emociclina
Eritrone
|
Erycytol
Erythrotin
Euhaemon
Extrinsic factor
Factor II
Fermin
Fresmin
Hemomin
Hepagon
Hepavis
Hepcovite
Hylugel plus
Infuvite Pediatric
Lactobacillus lactis dorner factor
M.V.I. Pediatric
Macrabin
Megabion
Megalovel
Milbedoce
Millevit
Nagravon
Nascobal
Neuroforte-R
Normocytin
Novidroxin
NSC-80365
Pernaemon
Pernaevit
Pernipuron
Plecyamin
Poyamin
Primabalt
Rebramin
Redamina
Redisol
Rhodacryst
Rubesol
RUBIVITE
Rubramin
RUBRAMIN PC
Rubratope-57 Kit
Rubratope-60 Kit
Rubripca
Rubrocitol
RUVITE
Shovite
Sytobex
Vibal
Vibalt
Vibisone
Virubra
Vitabee 12
VITAMIN B 12
Vitamin b12
Vitamin b12 complex
VITAMIN B12 NOS
Vitamin b12 preparation
vitamine b12
Vitaped
Vitarubin
Vita-rubra
Vitral
VI-TWEL
|
|
40 |
|
Pyridoxine |
Approved, Investigational, Nutraceutical, Vet_approved |
Phase 4 |
|
65-23-6 |
1054 |
Synonyms:
2-METHYL-3-HYDROXY-4,5-BIS(HYDROXYMETHYL)PYRIDINE
2-METHYL-3-HYDROXY-4,5-DI(HYDROXYMETHYL)PYRIDINE
2-METHYL-3-HYDROXY-4,5-DIHYDROXYMETHYLPYRIDINE
2-METHYL-4,5-BIS(HYDROXYMETHYL)-3-HYDROXYPYRIDINE
2-METHYL-4,5-DIMETHYLOL-PYRIDIN-3-OL
3-HYDROXY-2-PICOLINE-4,5-DIMETHANOL
3-HYDROXY-4,5-BIS(HYDROXYMETHYL)-2-METHYLPYRIDINE
3-HYDROXY-4,5-DIMETHYLOL-ALPHA-PICOLINE
3-Hydroxy-4,5-dimethylol-a-picoline
3-Hydroxy-4,5-dimethylol-α-picoline
4,5-BIS(HYDROXYMETHYL)-2-METHYL-PYRIDIN-3-OL
5-HYDROXY-6-METHYL-3,4-PYRIDINEDIMETHANOL
ADERMINE
GRAVIDOX
HEXA-BETALIN
|
HYDOXIN
M.V.I.-12
PIRIDOSSINA
PIRIDOXINA
PYRIDOXIN
PYRIDOXINE
PYRIDOXINE (VIT B6)
Pyridoxine hydrochloride
PYRIDOXINUM
PYRIDOXOL
Pyridoxol hydrochloride
PYRIDOXOLUM
Rodex
VITAMIN B6
|
|
41 |
|
Choline |
Approved, Nutraceutical |
Phase 4 |
|
62-49-7 |
305 |
Synonyms:
(2-Hydroxyethyl)trimethyl ammonium
(2-Hydroxyethyl)trimethylammonium
(2-HYDROXYETHYL)TRIMETHYLAZANIUM
(beta-Hydroxyethyl)trimethylammonium
2-HYDROXYETHYL-TRIMETHYL-AMMONIUM
2-HYDROXYETHYL-TRIMETHYL-AZANIUM
2-Hydroxy-N,N,N-trimethylethanaminium
2-Hydroxy-N,N,N-trimethyl-ethanaminium
Bilineurine
Biocolina
Biocoline
Bitartrate, choline
Bursine
Chloride, choline
CHOLINE
Choline bitartrate
Choline cation
Choline chloride
Choline citrate
Choline hydroxide
|
CHOLINE ion
Choline O sulfate
Choline O-sulfate
Cholinum
Citrate, choline
Fagine
Hepacholine
Hormocline
Hydroxide, choline
Lipotril
N,N,N-Trimethylethanolammonium
N,N,N-Trimethylethanol-ammonium
Neocolina
N-Trimethylethanolamine
O-Sulfate, choline
Paresan
Trimethylethanolamine
Vidine
Vitamin J
|
|
42 |
|
Niacin |
Approved, Investigational, Nutraceutical |
Phase 4 |
|
59-67-6 |
938 |
Synonyms:
[<sup>3</sup>H]-nicotinic acid
3 Pyridinecarboxylic acid
3-CARBOXYLPYRIDINE
3-CARBOXYPYRIDINE
3-PICOLINIC ACID
3-PYRIDINECARBOXYLATE
3-PYRIDINECARBOXYLIC ACID
3-PYRIDYLCARBOXYLATE
3-PYRIDYLCARBOXYLIC ACID
ACIDE NICOTINIQUE
ACIDO NICOTINICO
ácido nicotínico
ACIDUM NICOTINICUM
AKOTIN
Aluminum salt, niacin
ANTI-PELLAGRA VITAMIN
APELAGRIN
beta-Pyridinecarboxylate
BETA-PYRIDINECARBOXYLIC ACID
b-Pyridinecarboxylate
b-Pyridinecarboxylic acid
DASKIL
EFACIN
ENDURACIN
Hydrochloride, niacin
INDURACIN
LINIC
Lithium nicotinate
m-Pyridinecarboxylate
M-PYRIDINECARBOXYLIC ACID
NIAC
NIACIN
Niacin aluminum salt
Niacin ammonium salt
Niacin calcium salt
Niacin cobalt (2+) salt
Niacin copper (2+) salt
Niacin hydrochloride
Niacin iron (2+) salt
Niacin lithium salt
Niacin lithium salt, hemihydrate
Niacin magnesium salt
Niacin manganese (2+) salt
Niacin potassium salt
Niacin sodium salt
Niacin tartrate
NIACIN TD
Niacin tosylate
Niacin zinc salt
niacin|nicotinate|vitamin B<sub>3</sub>|vitamin PP
Niacina
NIACINE
|
NIACOR
NIASPAN
NIASPAN ER
NIASPAN TITRATION STARTER PACK
NICACID
NICAMIN
NICANGIN
Nico 400
Nico400
Nico-400
NICOBID
NICOCAP
NICODELMINE
NICOLAR
NICONACID
NICOSAN 3
NICO-SPAN
NICOTINATE
Nicotinate, lithium
NICOTINIC ACID
NICOTINIPCA
NICYL
NIKOTINSAEURE
Nikotinsäure
NSC-169454
NYCLIN
P.P. FACTOR
PELLAGRA PREVENTIVE FACTOR
PELLAGRIN
PELONIN
PEVITON
Potassium salt, niacin
PP FACTOR
PYRIDINE-3-CARBOXYLIC ACID
Pyridine-b-carboxylate
Pyridine-b-carboxylic acid
Pyridine-beta-carboxylate
PYRIDINE-BETA-CARBOXYLIC ACID
Pyridine-β-carboxylate
PYRIDINE-Î’-CARBOXYLIC ACID
SIMCOR
SLO-NIACIN
Sodium salt, niacin
Tartrate, niacin
TINIC
Tosylate, niacin
VITAMIN B3
VITAMIN PP
WAMPOCAP
Î’-pyridinecarboxylate
Î’-PYRIDINECARBOXYLIC ACID
|
|
43 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)FORMAMIDO]PENTANEDIOIC ACID
(2S)-2-[[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]-OXO-METHYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]GLUTARIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID
[<sup>3</sup>H]-folic acid
Acide folique
ácido fólico
Acidum folicum
ACIFOLIC
Apo-Folic
B03BB01
b9, Vitamin
BIO SCIENCE
CYTOFOL
DOSFOLAT B ACTIV
FOLACID
FOLACIN
FOLATE
FOLBAL
FOLCIDIN
FOLDINE
FOLETTES
FOLIAMIN
FOLIC ACID
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
FOLICARE
FOLICET
FOLIPAC
|
FOLSAEURE
FOLSAN
FOLSAURE
Folsäure
FOLSAV
FOLVITE
Folvron
INCAFOLIC
LEXPEC
LIVER LACTOBACILLUS CASEI FACTOR
MILLAFOL
N-(4-{[(2-AMINO-4-OXO-3,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)-L-GLUTAMIC ACID
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)CARBONYL]-L-GLUTAMIC ACID
N-[4-[[(2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL]AMINO]BENZOYL]-L-GLUTAMIC ACID
NATUR FLOW
N-Pteroyl-L-glutamate
N-PTEROYL-L-GLUTAMIC ACID
NSC-3073
PGA
PRECONCEIVE
PTEGLU
PTEROYLGLUTAMATE
PTEROYLGLUTAMIC ACID
PTEROYL-L-GLUTAMATE
PTEROYL-L-GLUTAMIC ACID
PTEROYL-L-MONOGLUTAMATE
PTEROYL-L-MONOGLUTAMIC ACID
PTEROYLMONOGLUTAMIC ACID
ROCHE
Vitamin B9
VITAMIN BC
VITAMIN BE
VITAMIN M
|
|
44 |
|
Tocotrienol |
Investigational |
Phase 4 |
|
6829-55-6 |
9929901 |
Synonyms:
|
45 |
|
Candesartan |
Experimental |
Phase 4 |
|
139481-59-7 |
2541 |
Synonyms:
2-Ethoxy-1-(p-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate
2-Ethoxy-1-(p-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4Ethyl]}-1H-benzimidazole-7-carboxylate
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4Ethyl]}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole
Amias
Atacand
|
Blopress
Candesartan
Candesartan cilexetil
CANDESARTAN CILEXETIL RELATED COMPOUND G
CV-11974
CV-11974|TCV-116 (prodrug)
Ratacand
TCV-116 (PRODRUG)
|
|
46 |
|
Cobalamin |
Experimental |
Phase 4 |
|
13408-78-1 |
6857388 |
Synonyms:
5,6-Dimethyl-1-a-D-ribofuranosyl-1H-benzimidazole
5,6-Dimethyl-1-a-D-ribofuranosylbenzimidazole
5,6-Dimethyl-1-alpha-delta-ribofuranosyl-1H-benzimidazole
5,6-Dimethyl-1-alpha-delta-ribofuranosylbenzimidazole
a-(5,6-Dimethylbenzimidazolyl)cobamide
alpha-(5,6-Dimethylbenzimidazolyl)cobamide
b 12, Vitamin
b12, Vitamin
Cbl
Cob(III)alamin
Cobalamin (III)
Cobalamin(1+)
Cobalamin(III)
Cobalamine
|
Cobalamins
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosyl-1H-benzimidazole
Cyanocobalamin
Eritron
Hydroxomin
Rubivite
Rubratope-57
Rubratope-60
Ruvite
Vitamin b 12
Vitamin b12
Α-(5,6-dimethylbenzimidazolyl)cobamide
|
|
47 |
|
Sodium-Glucose Transporter 2 Inhibitors |
|
Phase 4 |
|
|
|
48 |
|
Tocotrienols |
|
Phase 4 |
|
|
|
49 |
|
Tocopherols |
|
Phase 4 |
|
|
|
50 |
|
Dopamine agonists |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 1013)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study) |
Unknown status |
NCT02035644 |
Phase 4 |
Jinlida granules;placebo granules |
2 |
An Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate Simvastatin 20 mg Plus Omacor 4g Compared to Simvastatin 20 mg Plus Placebo in Subjects With Mixed Dyslipidemia |
Unknown status |
NCT00678743 |
Phase 4 |
Omacor + simvastatin |
3 |
Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia by Aripiprazole Add-on Therapy in the Treatment of Schizophrenia and Bipolar Disorder: An Open-Label Trial |
Unknown status |
NCT00541554 |
Phase 4 |
Abilify (aripiprazole) |
4 |
A Multi-center, Randomized, Parallel Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients With Dyslipidemia and Hypertension |
Unknown status |
NCT03860220 |
Phase 4 |
NEWSTATIN TS;CADUET |
5 |
Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia: A Network Register-based Follow-up Study |
Unknown status |
NCT03418974 |
Phase 4 |
Pitavastatin;Atorvastatin;Rosuvastatin |
6 |
Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)-A Randomized Controlled Trial |
Unknown status |
NCT00712049 |
Phase 4 |
simvastatin;Nicotinic Acid |
7 |
An Open-label, Randomized, Multi-centre, Phase IVb, Parallel Study Group to Compare the Efficacy and Safety of 5 mg and 10 mg Rosuvastatin |
Unknown status |
NCT01613729 |
Phase 4 |
Rosuvastatin 5 mg;Rosuvastatin 10 mg |
8 |
Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia |
Unknown status |
NCT01010516 |
Phase 4 |
High-dose rosuvastatin;Statin plus fenofibrate;Statin plus niacin ER/laropiprant |
9 |
EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial |
Unknown status |
NCT03932721 |
Phase 4 |
Evolocumab 140 MG/ML |
10 |
A Multi-center, Randomized, Double-blind, Parallel Phase â…£ Study to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy |
Unknown status |
NCT03874260 |
Phase 4 |
Fenofibrate |
11 |
A Multi-center, Open-label, Randomized, 12-month, Parallel-group, Non-inferiority Study to Compare the Hemoglobin A1C Metabolism of Pitavastatin Therapy Versus Atorvastatin in Chinese Patients With Prediabetes and Hypertension |
Unknown status |
NCT03532620 |
Phase 4 |
Pitavastatin Calcium;Atorvastatin Calcium |
12 |
An Randomized Open Label Trial on the Impact of 24 Weeks of Atorvastatin Therapy on Liver Fat Content and Abdominal Fat Content in Patients With Type 2 Diabetes Combined With High LDL-C and Non-alcoholic Fatty Liver Disease |
Unknown status |
NCT01720719 |
Phase 4 |
atorvastatin;Vitamin E |
13 |
A RANDOMIZED, DOUBLE-BLIND, ACTIVE CONTROLLED, PARALLEL GROUP STUDY OF PITAVASTATIN 4 MG VS. PRAVASTATIN 40 MG IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA |
Completed |
NCT01256476 |
Phase 4 |
pitavastatin;pravastatin |
14 |
A Single-Arm, Open-Label, Multicenter Study Evaluating the Triglyceride Changes in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia Following Treatment Conversion From Rosiglitazone to Pioglitazone HCl in Combination With Stable Statin Therapy |
Completed |
NCT00672919 |
Phase 4 |
Pioglitazone |
15 |
Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia |
Completed |
NCT00651963 |
Phase 4 |
ezetimibe |
16 |
Comparison of Pitavastatin With Atorvastatin in Increasing HDL-C and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease. |
Completed |
NCT00861861 |
Phase 4 |
Pitavastatin;Atorvastatin |
17 |
Efavirenz to Nevirapine Switch in HIV-1 Infected Patients With Severe Dyslipidemia: A Randomized Controlled Study |
Completed |
NCT00405171 |
Phase 4 |
Nevirapine |
18 |
Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia: A Randomized, add-on, Placebo-controlled Clinical Trial |
Completed |
NCT03906539 |
Phase 4 |
Atorvastatin 10mg |
19 |
Efficacy of Atorvastatin Versus Rosuvastatin on LV Function and Inflammatory Biomarkers in Type 2 Diabetic Patients With Dyslipidemia |
Completed |
NCT03784703 |
Phase 4 |
Atorvastatin 40 Mg Oral Tablet;Rosuvastatin 10 Mg Oral Tablet |
20 |
A Randomized, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Alirocumab Versus Usual Care in Patients With Type 2 Diabetes and Mixed Dyslipidemia at High Cardiovascular Risk With Non-HDL-C Not Adequately Controlled With Maximally Tolerated Statin Therapy |
Completed |
NCT02642159 |
Phase 4 |
Alirocumab;Statins;Ezetimibe;Fenofibrate;Nicotinic acid;Omega-3 fatty acids;Antihyperglycemic Drug |
21 |
A Phase IV, Randomized, Open-label, Parallel-arm, Comparative and Forced- Titration Study to Compare the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Patients With Type 2 DM and Dyslipidemia |
Completed |
NCT00506961 |
Phase 4 |
Rosuvastatin;Simvastatin |
22 |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia. |
Completed |
NCT00663845 |
Phase 4 |
Levitra (Vardenafil, BAY38-9456);Placebo |
23 |
Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients |
Completed |
NCT00654628 |
Phase 4 |
ezetimibe (+) simvastatin |
24 |
Dapagliflozin on Cholesterol Metabolism in DM2: Dissecting Its Effect on Dyslipidemia by Using Stable Isotope Based Cholesterol and Glucose Fluxes |
Completed |
NCT03074630 |
Phase 4 |
Dapagliflozin;Rosuvastatin |
25 |
A Multicenter, Pragmatic Randomized, Double-blind, Placebo-controlled Trial of Xuezhikang Capsule for Treating Dyslipidemia: a Postmarketing Study |
Completed |
NCT02057302 |
Phase 4 |
Xuezhikang capsule |
26 |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia |
Completed |
NCT00379756 |
Phase 4 |
LEVITRA (vardenafil);placebo |
27 |
Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-blind, Crossover Study |
Completed |
NCT02442700 |
Phase 4 |
pitavastatin;placebo |
28 |
Efficacy and Safety of Extended Release Niacin-Fenofibrate Combination and Monotherapy for the Treatment of Atherogenic Dyslipidemia in Obese Females |
Completed |
NCT03615534 |
Phase 4 |
Fenofibrate |
29 |
Extended-Release Niacin/Lovastatin Versus Usual Care for Treatment of Dyslipidemia in a Primary Care Setting (EXTEND Study) |
Completed |
NCT00345657 |
Phase 4 |
Niacin Extended Release/Lovastatin |
30 |
Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia |
Completed |
NCT00304993 |
Phase 4 |
fenofibrate;niacin;rosiglitazone |
31 |
A Randomized, Open, Parallel, Multicenter, Phase 4 Study to Evaluate the Central Aortic Pressure Effect Between Fixed Dose Combination (Duowell® Tab) and Monotherapy of Telmisartan in Mild Dyslipidemia Patients With Hypertension |
Completed |
NCT03267329 |
Phase 4 |
Duowell®;Telmisartan |
32 |
Open-label, Randomized, Single Center, Paralleled Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia |
Completed |
NCT04061824 |
Phase 4 |
Olostar Tab (olmesartan/rosuvastatin FDC(fixed dose combination));Two separated drugs(ARB(Angiotensin â…¡ receptor blocker) and statin) |
33 |
Randomized, Multicenter, Parallel, Open, Phase 4 Study to Compare the Efficacy and Safety of Rosuvastatin/Amlodipine Combination Therapy Versus Atorvastatin/Amlodipine Combination Therapy in Hypertension Patient With Dyslipidemia |
Completed |
NCT03951207 |
Phase 4 |
Rosuampin 10/5mg;Rosuampin 20/5mg;Amlodipine/Atorvastatin 5/20mg |
34 |
A 12-Week, Double-Blind, Randomized, Placebo-Controlled Study to Assess the LDL Cholesterol Lowering and Anti-Hyperglycemic Efficacy of Welchol® (Colesevelam) in Subjects With Impaired Fasting Glucose Who Are Taking Niaspan® (Niacin) for Dyslipidemia |
Completed |
NCT01239004 |
Phase 4 |
Placebo;Colesevelam |
35 |
Prospective, Randomised, Crossover, Double-Blind, Placebo-Controlled Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors |
Completed |
NCT01458977 |
Phase 4 |
Truvada® (300 mg tenofovir disoproxil fumarato/200 mg emtricitabine);Placebo |
36 |
Metformin for Treatment of Antipsychotic-induced Dyslipidemia: a Randomized, Double-blind Study |
Completed |
NCT01778244 |
Phase 4 |
metformin |
37 |
Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents |
Completed |
NCT01502904 |
Phase 4 |
pravastatin 20mg/day after DES implantation;pitavastatin 2mg/day after DES implantation;Non-ARB /day after DES implantation;Eposartan 600mg/day after DES implantation |
38 |
A 12-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects With Dyslipidemia, Followed by a 40-Week Safety Extension Study |
Completed |
NCT01301066 |
Phase 4 |
Pitavastatin;Pravastatin |
39 |
A 12-week, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel-group Study to Assess the Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily Compared to Fluvastatin Sodium Immediate Release Capsules 40 mg Twice Daily (BID) in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia at Moderate or High Cardiovascular Risk Who Did Not Achieve Their Lipid Goals When Treated With Fluvastatin Sodium Immediate Release Capsules 40 mg QD |
Completed |
NCT01551173 |
Phase 4 |
Fluvastatin sodium |
40 |
Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels in Healthy, Hyperlipidemic Subjects |
Completed |
NCT00441480 |
Phase 4 |
|
41 |
A 6-Week, Prospective, Randomized, Double-Blind, Double-Dummy Phase IV Clinical Trial Designed to Evaluate the Efficacy of an Aggressive Multi-Risk Factor Management Strategy With Caduet (A3841045) Versus a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensive Subjects With Additional Risk Factors. |
Completed |
NCT00412113 |
Phase 4 |
Amlodipine besylate;Amlodipine besylate/atorvastatin calcium single pill combination |
42 |
Comparison of the Effect Noted in The Apo/Apo-1 Ratio Using Rosuvastatin and Atorvastatin in Patients With acUte Coronary Syndrome CENTAURUS Study |
Completed |
NCT00665834 |
Phase 4 |
rosuvastatin;placebo;atorvastatin |
43 |
An Outcome Research on the Impact of a Disease Management Program (COACH) on the Attainment of Better Cardiovascular Risk Control in Dyslipidemic Patients at Primary Care Centers (DISSEMINATE). |
Completed |
NCT00708370 |
Phase 4 |
|
44 |
Effect of Atorvastatin Therapy on Fibrous Cap Thickness in Coronary Atherosclerotic Plaque as Assessed by Optical Coherence Tomography |
Completed |
NCT00700037 |
Phase 4 |
high-dose atorvastatin;low-dose atorvastatin |
45 |
The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients |
Completed |
NCT02103049 |
Phase 4 |
Ezetimibe |
46 |
ACTFAST (2): Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration: A Multicenter, Twelve-Week Treatment, Single-Step Titration, Open-Label Study Assessing The Percentage Of Dyslipidemic High-Risk Patients Achieving Low Density Lipoprotein Cholesterol (LDL-C) Target With Atorvastatin Starting Doses Of 10 mg, 20 mg, 40 mg, And 80 mg. |
Completed |
NCT00442325 |
Phase 4 |
Atorvastatin (Lipitor) |
47 |
Atorvastatin Action on Oxidative Stress and Inflammation in Type II Diabetes: The HDL Particle Protection Study |
Completed |
NCT02125682 |
Phase 4 |
atovastatin 10 mg/day;Atorvastatin 80 mg/day |
48 |
Effect of Atazanavir on Endothelial Function in HIV-Infected Patients Compared to Standard Proteinase Inhibitors on Top of Potent Antiviral Combination Therapy |
Completed |
NCT00447070 |
Phase 4 |
ATAZANAVIR |
49 |
A 16-week Multicenter, 2-period Study to Investigate the Effect of the Combination of Fluvastatin ER 80mg and Fenofibrate 200mg on HDL-C in Comparison to the Combination of Simvastatin 20mg and Ezetimibe 10mg in Patients With Metabolic Syndrome |
Completed |
NCT00385658 |
Phase 4 |
Fluvastatin extended release, fenofibrate;Fixed combination simvastatin/ezetimibe |
50 |
ACTFAST: Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration. A Multicenter, Twelve-Week Treatment, Single Step Titration, Open-Label Study Assessing The Percentage Of Dyslipidemic High-Risk Patients Achieving Low Density Lipoprotein Cholesterol (LDL-C) Target With Atorvastatin Starting Doses Of 10 Mg, 20 Mg, 40 Mg, And 80 Mg |
Completed |
NCT00442845 |
Phase 4 |
Atorvastatin (Lipitor) |
|